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Abstract
The study of HutchinsonGilford progeria syndrome (HGPS) has provided important 
clues to decipher mechanisms underlying aging. Progerin, a mutant lamin A, disrupts 
nuclear envelope structure/function, with further impairment of multiple processes 
that culminate in senescence. Here, we demonstrate that the nuclear protein ex-
port pathway is exacerbated in HGPS, due to progerin-driven overexpression of 
CRM1, thereby disturbing nucleocytoplasmic partitioning of CRM1-target proteins. 
Enhanced nuclear export is central in HGPS, since pharmacological inhibition of 
CRM1 alleviates all aging hallmarks analyzed, including senescent cellular morphol-
ogy, lamin B1 downregulation, loss of heterochromatin, nuclear morphology defects, 
and expanded nucleoli. Exogenous overexpression of CRM1 on the other hand re-
capitulates the HGPS cellular phenotype in normal fibroblasts. CRM1 levels/activity 
increases with age in fibroblasts from healthy donors, indicating that altered nuclear 
export is a common hallmark of pathological and physiological aging. Collectively, 
our findings provide novel insights into HGPS pathophysiology, identifying CRM1 as 
potential therapeutic target in HGPS.
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ゲ科 |科INTRODUC TION
Aging is a universal process that occurs across all living species; in 
humans, aging is characterized by a gradual decline in physical and 
psychological capacities that in turn cause morphological, metabolic, 
and cognitive alterations that limit the quality of life and ultimately 
provoke death. Premature aging syndromes, a group of extremely 
rare but devastating disorders that mimic physiological aging, have 
been proposed as models to decipher the molecular mechanisms un-
der旭ying	aging	ｪKubben	ｹ	Miste旭ip	ゴグゲゼｫs
HutchinsonGilford progeria syndrome (HGPS), the most well-
studied progeroid syndrome, is typically caused by a silent point mu-
tation (1824C > T) that activates a cryptic splicing site within exon 11 
of the LMNA gene, resulting in the synthesis of a prelamin A mRNA 
that contains an internal deletion of 150 base pairs. Consequently, 
this leads to the translation of a mutant lamin A termed progerin, 
which harbors a deletion of 50 amino acids within its C-terminus. 
Progerin is permanently farnesylated because the deletion elimi-
nates the cleavage site for Zmpste24, the enzyme that removes the 
C-terminal farnesyl group from prelamin A to render mature lamin A 
(Eriksson et al., 2003; De Sandre-Giovannoli et al., 2003).
Progerin acts in a dominant gain-of-function manner by anchor-
ing to the nuclear envelope and perturbing nuclear lamin function, 
thereby inducing a plethora of cellular defects, including aberrant 
nuclear morphology, altered DNA repair and gene expression, and 
te旭omere	 instabi旭ity	 ｪGonza旭op	 Kreienkampp	 ｹ	 Askjaerp	 ゴグゲゼｫs	 The	
complex network of downstream effects by which progerin exerts 
its toxicity is far from understood; it is thought that progerin impacts 
on central cellular process, which in turn triggers a cascade of nox-
ious downstream effects that ultimately cause aging.
Owing to the deleterious effect exerted by progerin on nuclear 
envelope, we hypothesized that the nucleocytoplasmic transport 
of proteins through the nuclear pore complex (NPC) (Christie et 
al., 2016) could be a primary target of progerin. Supporting our hy-
pothesis, perturbation in the Ran GTPase gradient affecting nuclear 
import of specific proteins, namely Ubc9, and nucleoporin TPR was 
previously reported in HGPS cells (Cobb et al., 2016; Snow, Dar, 
Duttap	Keh旭enbachp	ｹ	Pascha旭p	 ゴグゲザｫs	 Furthermorep	 the	nonc旭assic	
transport pathway mediated by transportin-1 (TNPO1) is impaired 
in HGPS cells, due to cytoplasmic sequestration of TNPO1 by the 
microtubule network (Larrieu et al., 2018).
In this study, we aimed to analyze whether nuclear protein export 
is impaired in HGPS. Exportin-1 (XPO1), also known as chromosomal 
region maintenance 1 (CRM1), binds to cargo proteins through a 
leucine-rich nuclear export signal (NES) and transports the proteins 
across the NPC via a Ran-GTP gradient (Ishizawa, Kojima, Hail, Tabe, 
ｹ	Andreeffp	ゴグゲズq	Kir旭i	et	a旭sp	ゴグゲズｫs	We	show	for	the	first	time	that	
the CRM1-driven nuclear protein export mechanism is abnormally 
enhanced in HGPS fibroblasts and that this novel hallmark is critically 
involved in the disease, because pharmacological inhibition of CRM1 
rescues the HGPS cellular phenotype and exogenous overexpression 
of CRM1 recapitulates HGPS in normal fibroblasts.
ゴ科 |科RESULTS
ゴsゲ科|科Enhanced CRMゲ､driven nuc旭ear protein export 
is a novel hallmark of HGPS cells
To ascertain whether the CRM1-mediated nuclear protein export 
mechanism is impaired in HGPS, we evaluated the subcellular dis-
tribution of six different proteins whose nuclear export depends 
on NES recognition by CRM1 (STAT3, B23, ZO-2, cyclin B1, Dp71, 
and HDAC1). Two different HGPS fibroblast cultures (HGPS-1 and 
HGPS､ゴｫ	 and	 a	 passage､matched	 fibrob旭ast	 contro旭	 cu旭ture	 ｪWTｫ	
were examined using confocal laser scanning microscopy (CLSM). 
There was a significant decrease in the nuclear localization with a 
concomitant increase in the cytoplasmic labeling for all the analyzed 
proteins in both HGPS cell cultures, with the exception of HDAC1 
that was found to be mislocalized only in HGPS-2 cells (Figure 1a 
and Figure S1). Quantitative analysis of the fluorescence nuclear/cy-
toplasmic ratio (Fn/c) corroborated these observations (see graphs). 
Nuclear accumulation of NES-containing proteins was restored to 
a	 simi旭ar	 旭eve旭	 to	 that	 of	WT	 ce旭旭s	 upon	 treatment	 of	 HGPS	 ce旭旭s	
for 1 day with 1 nM leptomycin B (LMB), a specific CRM1 inhibitor 
(Figure 1a and Figure S1). This clearly indicates that their nuclear 
depletion is caused by enhanced nuclear export activity rather than 
nuclear import failure. Next, we analyzed the expression of NES-
containing proteins in HGPS cells. The levels of STAT3 and B23 were 
simi旭ar	between	WT	and	HGPS	ce旭旭sp	whi旭e	an	apparent	increase	for	
ZO-2 was observed only in HGPS-2 fibroblasts (Figure 1b).
ゴsゴ科|科Enhanced nuc旭ear protein export in HGPS ce旭旭s 
is caused by progerin-induced CRM1 overexpression
We	 hypothesized	 that	 the	 exacerbated	 nuc旭ear	 export	 activity	
of HGPS cells might be consequence of CRM1 overexpression. 
Consistent with this idea, elevated CRM1 protein levels were found 
in HGPS cells (Figure 1c,d), with qRT-PCR experiments showing a 
corresponding increase in CRM1 mRNA levels (Figure 1e). Given that 
CRM1 overexpression is primarily regulated at the transcriptional 
level, we next analyzed CRM1 promoter activity in HGPS cells by 
promoter reporter assays. An increase in CRM1 promoter activity 
was	found	in	HGPS､ゴ	but	not	HGPS､ゲ	ce旭旭sp	compared	with	WT	ce旭旭s	
(Figure 1f).
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F I G U R E  ゲ 科Mis旭oca旭ization	of	NES､containing	proteins	is	caused	by	progerin､mediated	overexpression	of	CRMゲs	ｪaｫ	Wi旭d､type	ｪWTｫ	
and HGPS cells, treated for 24 hr with 10 nM LMB or vehicle alone, were immunolabeled for the indicated proteins (bar, 10 µm). The Fn/c 
ratio was calculated (n	┎	ズグ	ce旭旭sｫp	and	significant	differences	were	determined	by	Mann･Whitney	U	test	ｪgraphsｫs	ｪbｫ	Protein	旭eve旭s	of	
STATザp	Bゴザp	ZO､ゴp	and	actin	ｪ旭oading	contro旭ｫ	were	ana旭yzedp	and	typica旭	ge旭s	from	two	independent	experiments	are	showns	ｪcｫ	WT	and	
HGPS cells were immunolabeled for CRM1 and analyzed by CLSM. Typical images from 3 independent assays are shown (bar 10 µm). (d) 
Lysates	from	WT	and	HGPS	ce旭旭s	were	subjected	to	Western	b旭ot	using	antibodies	against	CRMゲp	旭amin	A｠Cp	or	actin	ｪ旭oading	contro旭ｫp	and	
relative CRM1 levels were obtained (graph). (e) CRM1 messenger RNA expression was examined by qRT-PCR. (d-e) Significant differences 
were determined by unpaired t tests	ｪfｫ	WT	and	HGPS	ce旭旭s	were	transfected	with	both	Luciferase	reporter	construct	containing	the	
human CRM1 promoter and Renilla luciferase vector, which was used to normalize transfection efficiency. Enzymatic activities were 
estimated after incubation for 48 hr as described in Methods. Data represent mean ± SEM of three independent experiments (unpaired 
t	testｫs	ｪgｫ	Lysates	from	HeLa	ce旭旭s	stab旭y	transfected	to	express	GFP､旭amin	A	or	GFP､progerin	were	subjected	to	Western	b旭otting	using	
antibodies against CRM1, GFP, or actin (loading control). (h) HeLa cells expressing GFP-lamin A or GFP-progerin were subjected to 
chromatin immunoprecipitation (ChIP) with anti-NF-YA antibodies followed by PCR for the CRM1 promoter region. Data correspond to 
two independent experiments in triplicate
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To ascertain whether CRM1 overexpression is causally linked 
to progerin, we evaluated whether exogenous expression of pro-
gerin is sufficient to elicit increased CRM1 levels in HeLa cells. 
Expression of GFP-progerin but not GFP-lamin A resulted in nu-
clear morphology aberrations (Figure S2a), decreased H3K9m3 
levels (Figure S2b), and increased CRM1 levels (Figure 1g); the lat-
ter appears to provoke in turn cytoplasmic mislocalization of the 
NES､containing	 STATザ	 ｪFigure	 Sゴcｫs	We	 then	 eva旭uated	whether	
exogenously expressed progerin induces CRM1 promoter activ-
ity, using ChIP-qPCR assays to assess binding activity of NF-YA, a 
transcription factor that positively regulates the CRM1 promoter 
ｪvan	der	Watt	ｹ	 Leanerp	 ゴグゲゲｫs	 The	binding	 activity	 of	NF､YA	 to	
the CRM1 promoter region was found to be augmented by ~30% 
in GFP-progerin-expressing cells, compared with those expressing 
GFP-lamin A (Figure 1h).
Because progerin toxicity is attributed at least in part to 
its farnesyl moiety, we next examined whether inhibition of progerin 
farnesylation using the farnesyltransferase inhibitor (FTI) lonafarnib 
would reduce overexpression of CRM1 in HGPS cells. As previously 
reported (Noda et al., 2015), treatment with 25 µM of lonafarnib 
for 3 days elicited a significant decrease in both nuclear blebbing 
(Figure S3a) and progerin levels (Figure S3b). Supporting our idea, 
the decrease in progerin levels resulted in CRM1 downregulation 
(Figure S3b).
ゴsザ科|科Pharmaco旭ogica旭 attenuation of CRMゲ activity 
rescues premature senescence in HGPS cells by 
improving lamin B1 levels
We	wondered	whether	enhanced	CRMゲ	activity	might	be	part	of	
the molecular basis underlying HGPS. To address this, we evalu-
ated whether amelioration of CRM1 activity through LMB treat-
ment has an impact on cellular senescence. Remarkably, LMB 
treatment for 2 days resulted in a significant reduction of senes-
cence cells in HGPS cultures, as determined by senescence-asso-
ciated β-galactosidase (SA-β-gal) staining (Figure 2a). Consistent 
with this, the percentage of HGPS-1 and HGPS-2 cells arrested 
at G0/G1 phase of the cell cycle decreased upon treatment with 
LMBp	as	revea旭ed	by	f旭ow	cytometry	ana旭ysis	ｪFigure	Sジaｫs	We	next	
analyzed the effect of LMB on cell proliferation. Treatment with 
LMB for 3 days resulted in significantly decreased cell growth in 
both	WT	and	HGPS	ce旭旭sq	howeverp	 it	provoked	on旭y	a	 s旭ight	 in-
crease in cell death by the third day, as shown by MTT and an-
nexin V assays (Figure S4b,c, respectively). Since decreased lamin 
B1 expression is associated with senescence (Freund, Laberge, 
Demariap	ｹ	Campisip	ゴグゲゴq	Shimi	et	a旭sp	ゴグゲゲｫp	we	were	prompted	
to analyze whether treatment with LMB has a positive effect on 
lamin B1 levels. A ~80% decrease in lamin B1 levels was observed 
in HGPS cells incubated with vehicle alone. Nevertheless, par-
tial restitution of lamin B1 expression was obtained after incu-
bation of HGPS fibroblasts with LMB (50 nM) for 6 days, while 
no	changes	were	 found	 in	WT	ce旭旭s	upon	 treatment	 ｪFigure	ゴbｫs	
Redistribution of lamin B1 into distinct nucleoplasmic foci was 
observed in LMB-treated HGPS cells (Figure 2c). It is thought that 
nucleoplasmic foci of lamin B1 correspond to nascent lamin B1 
incorporated in the nucleoplasmic reticulum in interphase nuclei 
ｪDrozdzp	Jiangp	Pytowskip	Grovenorp	ｹ	Vauxp	ゴグゲゼｫs
We	considered	that	restoration	of	旭amin	Bゲ	旭eve旭s	might	conse-
quently reduce those HGPS characteristics governed by lamin B1 
ｪCamps	et	a旭sp	ゴグゲジｫs	We	 then	examined	 the	 impact	of	LMB	treat-
ment on heterochromatin organization using the heterochromatin 
marker H3K9me3. Supporting our idea, recovery of both nuclear 
staining and protein levels of H3K9me3 was evidenced in HGPS cells 
after LMB treatment (Figure 2d,e, respectively).
We	next	examined	the	effect	of	LMB	on	nuc旭ear	morpho旭ogyp	
using nuclear morphometric analyses. Nuclear defects were com-
monly found in vehicle-treated HGPS fibroblasts immunostained 
for	 旭amin	 A｠Cp	 compared	 with	WT	 ce旭旭s	 ｪFigure	 ザa	 and	 graphsｫs	
Remarkably, ovoid-shaped nuclei devoid of irregularities that re-
semb旭e	WT	nuc旭ei	were	evident	after	treatment	of	HGPS	ce旭旭s	for	
3 days with LMB (Figure 3a). Nuclear morphometric analyses con-
firmed significant differences between vehicle- and LMB-treated 
HGPS cells (right graphs). Collectively, these data indicate that 
mitigation of CRM1 activity through LMB treatment delayed the 
progression of HGPS cells to senescence by preventing lamin B1 
downregulation.
ゴsジ科|科Pharmaco旭ogica旭 modu旭ation of CRMゲ activity 
ameliorates aging features of HGPS cells
To analyze in depth the effect of LMB-mediated CRM1 inhibition 
on senescence, two distinctive features of senescent cells, namely 
enlarged nucleolar morphology and senescent cellular morphol-
ogy, were examined in HGPS fibroblasts. As reported previously, 
ｪBuchwa旭ter	ｹ	Hetzerp	ゴグゲゼｫp	 a	 sing旭e	or	 two	prominent	nuc旭eo旭i	
with increased nucleolar area were observed in most HGPS cells 
(Figure 3b). Notably, administration of LMB to HGPS cultures for 
3 days resulted in increased number of nucleoli per cell (Figure 3b), 
with smaller nucleolar area (right graphs), which were comparable 
in size to wild-type nucleoli. Previously, the expansion of nucleoli 
was linked to elevated protein synthesis in HGPS cells (Buchwalter 
ｹ	Hetzerp	ゴグゲゼｫs	Thereforep	we	were	prompted	to	ana旭yze	whether	
alleviation of nucleolar expansion by LMB treatment has an ef-
fect on global protein synthesis by monitoring the phosphoryla-
tion state of the α subunit of eukaryotic initiation factor 2 (eIF2α), 
the p70 ribosomal protein S6 kinase (p70 S6K) and its substrate, 
and the ribosomal protein S6 (rpS6). Consistent with elevated pro-
tein synthesis, HGPS-1 cells treated with vehicle alone showed 
decreased p-eIF2a levels but elevated levels of p-p70 S6K and p-
rpS6K (Figure 3c). By contrast, LMB treatment for 3 and 6 days 
resulted in increased p-eIF2α levels but reduced phosphorylated 
levels of both p70 S6K and rpS6 in HGPS-1 cells (Figure 3c), which is 
consistent with a translational repression effect mediated by LMB. 
With	 respect	 to	 the	 senescent	 ce旭旭	 morpho旭ogyp	 LMB､mediated	
科架 科 | 科ズ of ゲジGARCÍA-AGUIRRE ET AL.
inhibition of CRM1 activity shifted the flattened and expanded 
morphology of HGPS fibroblasts to the typical fusiform morphol-
ogy	of	WT	fibrob旭asts	ｪFigure	ザdｫp	with	a	concomitant	decrease	in	
cell size (right graph).
Finally, we assessed whether treatment with LMB has an effect 
on progerin expression. Interestingly, progerin levels were found to 
significantly decrease in HGPS-2 cells but not HGPS-1 cells upon 
LMB treatment (Figure S4c).
F I G U R E  ゴ 科LMB､mediated	inhibition	of	CRMゲ	prevents	ce旭旭u旭ar	senescence	by	improving	旭amin	Bゲ	旭eve旭ss	ｪaｫ	WT	and	HGPS	fibrob旭asts	
were treated for 2 days with 1 nM LMB or vehicle alone. The activity of β-galactosidase was assessed, and representative images are 




HGPS fibroblasts treated with 50 nM LMB or vehicle for 6 days were analyzed by CLSM, using antibodies against H3K9me3 and lamin A/C. 
Representative images are shown. B Bar, 10 µm. Bottom. Line profile analysis showing H3K9me3 fluorescence pattern. (e) Lysates from 
HGPS	ce旭旭s	treated	as	peer	C	were	ana旭yzed	by	Western	b旭otting	using	antibodies	against	HザKゾmeザ	and	actin	ｪcontro旭ｫs	Re旭ative	HザKゾmeザ	
levels are shown (right graph). (b and e) Significant differences were determined by unpaired t test
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F I G U R E  ザ 科LMB､mediated	inhibition	of	CRMゲ	a旭旭eviates	aging	features	of	HGPS	ce旭旭ss	ｪaｫ	WT	and	HGPS	fibrob旭asts	were	treated	for	
3 days with 50 nM LMB or vehicle alone. Cells were immunolabeled for lamin A/C before being analyzed by CLSM, and representative 
images are shown. Bar, 10 µm. Right. Nuclear morphometric analysis was carried out as described in Methods (n = 200 nuclei for each 
conditionｫp	with	significant	differences	determined	by	Mann･Whitney	U	tests	ｪbｫ	WT	and	HGPS	fibrob旭astsp	treated	as	peer	Ap	were	
immunostained for fibrillarin to decorate nucleoli. Bar, 10 µm. Right. Nucleolar area was determined as described in Methods (n > 600 
nucleoli per condition). Number of nucleoli per cell was estimated (bottom panel; n > 80 cells per sample), and significant differences were 
determined	by	Mann･Whitney	U	tests	ｪcｫ	Lysates	from	WT	and	HGPS､ゲ	fibrob旭astsp	previous旭y	treated	for	グp	ザp	or	葦	days	with	ゲ	nM	LMB	or	
vehic旭ep	were	ana旭yzed	by	Western	b旭otting	using	antibodies	against	the	indicated	proteinss	Re旭ative	protein	旭eve旭s	from	three	independent	
experiments are shown (bottom graphs), with significant differences determined by unpaired t tests	ｪdｫ	WT	and	HGPS	fibrob旭asts	were	
treated as peer A. Cells were labeled with phalloidin to visualize actin cytoskeleton. Bar, 50 µM. Right. The cellular area was estimated 
(n	┒	ザググ	ce旭旭sｫp	with	significant	differences	determined	by	Mann･Whitney	U	test
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F I G U R E  ジ 科 Ectopic overexpression of CRM1 induces premature aging phenotype in normal primary fibroblasts. Human primary 
fibroblasts derived from a healthy donor were stably transfected to express Flag-CRM1 or Flag alone. (a) Lysates were subjected to 
Western	b旭otting	using	antibodies	against	CRMゲp	F旭agp	or	actin	ｪ旭oading	contro旭ｫs	Re旭ative	CRMゲ	旭eve旭s	are	shown	ｪright	pane旭ｫs	ｪbｫ	Subce旭旭u旭ar	
distribution of STAT3 was evaluated by CLSM and its n/c ratio estimated (graph). Bar, 10 µM. (c) The activity of β-galactosidase was 
measured, and the percentage of senescent cells was estimated from 3 independent experiments (n = 300 cells for condition). Bar, 100 µM. 
(a-c) Significant differences were determined by unpaired t test. (d) Transfected fibroblasts were labeled with phalloidin to visualize actin. 
Right. Flag-CRM1-expressing fibroblasts were treated with 50 nM LMB or vehicle alone for 3 days, prior to being stained with phalloidin and 
analyzed by CLSM. Bar, 50 µM. The cellular area was determined (n > 150 cells for condition), and significant differences were determined 
by	Mann･Whitney	U	tests	ｪeｫ	Lysates	from	fibrob旭asts	expressing	F旭ag	or	F旭ag､CRMゲp	which	were	previous旭y	treated	with	ズグ	nM	LMB	or	
vehic旭e	a旭one	for	six	daysp	were	ana旭yzed	by	Western	b旭otting	with	antibodies	against	旭amin	Bゲ	and	actin	ｪcontro旭ｫs	Bottom. Relative lamin B1 
levels are shown. Significant differences were determined by unpaired t test. (f) Transfected fibroblasts with or without LMB treatment were 
immunostained for lamin B1, and typical images are shown. Bar, 10 µm. Bottom. Line profile analysis showing lamin B1 fluorescence pattern. 
ｪgｫ	WT	fibrob旭asts	stab旭y	expressing	F旭ag	or	F旭ag､CRMゲ	were	treated	as	peer	ｪeｫ	prior	to	be	ana旭yzed	by	Western	b旭otting	for	HザKゾmeザs	
Bottom. Relative H3K9me3 levels are shown, and significant differences were determined by unpaired t test. (h) Nuclear distribution of 
H3K9me3 was analyzed in the indicated transfected fibroblasts with or without LMB treatment. Bottom. Line profile analysis showing the 
H3K9me3 fluorescence pattern
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ゴsズ科|科Ectopic overexpression of CRMゲ recreates the 
HGPS phenotype in normal human fibroblasts
Next, we ascertained whether exogenous overexpression of CRM1 
is sufficient to mimic progeroid hallmarks in normal fibroblasts. A 
~100% increase in CRM1 levels was observed after stable transfec-
tion	of	WT	fibrob旭asts	with	a	vector	expressing	FLAG､CRMゲp	com-
pared	to	WT	ce旭旭s	expressing	FLAG	a旭one	 ｪFigure	ジaｫs	Cytop旭asmic	
mislocalization of the NES-containing protein STAT3 confirmed 
accelerated nuclear export activity in cells overexpressing CRM1 
F I G U R E  ズ 科 (a-b) Enhanced nuclear export activity due to CRM1 overexpression overcomes deficient Ran gradient in HeLa cells. Cells 
were double-transfected to stably expressed Flag-CRM1 or Flag alone, and a shRNA against NTF2 gene or a shRNA control. (a) Lysates from 
the	transfected	ce旭旭s	were	ana旭yzed	by	Western	b旭otting	using	antibodies	against	CRMゲp	NTFゴp	and	actin	ｪcontro旭ｫs	Middle. Relative protein 
levels were assessed from three independent experiments (unpaired t test). Right. Distribution of STAT3 was analyzed in the indicated 
transfected	ce旭旭ss	Barp	ゴグ	拙Ms	ｪbｫ	Transfected	ce旭旭	旭ysates	were	ana旭yzed	by	Western	b旭otting	with	antibodies	against	旭amin	Bゲp	HザKゾmep	and	
actin (control). Middle. Data correspond to 3 independent experiments (unpaired t test). Right. Distribution of H3K9me3 was analyzed in the 
indicated transfected cells. Bar, 20 µM. (ce) Restoration of lamin B1 expression in HGPS cells (c) HGPS-1 cells were transiently transfected 
to express GFP-lamin B1 or GFP alone. Transfected cells were immunolabeled for lamin A/C (d) and H3K9m3 (e) to estimate the percentage 
of cells with aberrant nuclear morphology and heterochromatin loss, respectively. Bar, 10 µM
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ｪFigure	 ジbｫs	 Remarkab旭yp	most	 of	 CRMゲ､overexpressing	WT	 fibro-
blasts became senescent (75%), as shown by SA-β-gal staining and 
the acquisition of a flattened and extended cellular morphology 
(Figure 4c,d, respectively). Furthermore, forced overexpression 
of	 CRMゲ	 in	WT	 fibrob旭asts	 resu旭ted	 in	 decreased	 旭amin	 Bゲ	 旭eve旭s	
(Figure 4ef), with the consequent loss of H3k9m3 (Figure 4gh). 
Interestingly, pharmacological inhibition of CRM1 in FLAG-CRM1-ex-
pressing fibroblasts alleviated the senescent morphology (Figure 4d) 
and prevented both lamin B1 downregulation (Figure 4e,f) and the 
loss of heterochromatin (Figure 4g,h).
The gradient of Ran, a key regulator of nucleocytoplasmic trans-
port, was previously reported as disrupted in HGPS cells (Datta, 
Snowp	 ｹ	 Pascha旭p	 ゴグゲジｫs	 We	 therefore	 investigated	 whether	 en-
hanced nuclear export activity via CRM1 overexpression can occur 
in cells with a deficient Ran gradient. Since depletion of the Ran im-
port factor NTF2 (nuclear transport factor 2) is sufficient to disrupt 
the Ran gradient (Datta et al., 2014; Dworak et al., 2019), HeLa cells 
were double-transfected to express CRM1 and a shRNA against 
NTF2. Interestingly, stably transfected HeLa cells having both over-
expressed levels of CRM1 and depleted levels of NTF2 (Figure 5a) still 
F I G U R E  葦 科 CRM1 expression and activity increased during normal aging. (a) Primary human fibroblast from healthy individuals of varying 
ages	or	HGPS､ゲ	fibrob旭asts	were	ana旭yzed	by	Western	b旭otting	using	antibodies	against	CRMゲp	旭amin	A｠Cp	and	actin	ｪcontro旭ｫs	CRMゲ	
expression is shown (bottom panel; unpaired t test). (b) Localization of the NES-containing proteins STAT3, Z0-2, and B23 was evaluated 
in the indicated fibroblast cultures, treated with LMB or vehicle alone for 24 hr. Typical images are shown. Bar, 20 µM. (c) The n/c ratio of 
STAT3, Z0-2, and B23 was calculated as peer Methods (n	┎	ズグ	ce旭旭sq	Mann･Whitney	U	testｫ
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showed elevated nuclear export activity, as shown by cytoplasmic 
mislocalization of the NES-containing protein STAT3 (right panel). 
Consequently, these cells acquired different aging marks, including 
depleted levels of lamin B1 and H3K9m3 (Figure 5b). Collectively, 
these data imply that enhancing CRM1 activity is necessary and suf-
ficient to induce the cells to age prematurely.
ゴs葦科|科Exogenous restoration of 旭amin Bゲ 旭eve旭s 
partially alleviates the HGPS phenotype
To ascertain whether improvement of lamin B1 levels by LMB treat-
ment is the basis of the HGPS phenotype rescue, the expression of 
lamin B1 was exogenously restored in HGPS-1 cells by stably trans-
fecting a vector expressing GFP-lamin B1. GFP-lamin B1 was prop-
erly targeted to the nuclear envelope, while GFP alone was localized 
throughout all the cells (Figure 5c). Remarkably, HGPS cells express-
ing GFP-lamin B1 showed improved nuclear morphology (Figure 5d) 
and recovery of peripheral heterochromatin (Figure 5e), compared 
with HGPS-1 cells expressing GFP alone. However, restoration of 
lamin B1 expression failed to alleviate the senescent morphology 
(data not shown).
ゴsゼ科|科The expression and activity of CRMゲ increase 
during normal aging
We	hypothesized	that	the	CRMゲ､mediated	nuc旭ear	export	system	
could be dysregulated during normal aging as well. Thus, we ana-
lyzed expression and activity of CRM1 in a panel of primary human 
fibroblasts from healthy individuals ranging from 10 to 91 years 
of age. Interestingly, we found a significant and direct correlation 
between aging and increased CRM1 levels in individuals between 
38 and 91 years of age (Figure 6a). Cytoplasmic mislocalization of 
the NES-containing proteins STAT3, Z0-2, and B23 was evident 
in fibroblasts from 74- to 91-year-old individuals (Figure 6b), with 
Fn/C analysis corroborating these observations (Figure 6c); further 
treatment with LMB restored predominant nuclear localization of 
NES-containing proteins, similar to that observed in fibroblasts 
from 10- to 38-year-old individuals (Figure 6b-c). Altogether, these 
data suggest that enhanced CRM1 activity is a hallmark of physi-
ological aging.
ザ科 |科DISCUSSION
In this study, we show for the first time that the CRM1-driven nu-
clear protein export mechanism is abnormally enhanced in HGPS 
ce旭旭s	 due	 to	overexpression	of	CRMゲs	We	 revea旭ed	 that	upregu-
lation of CRM1 in HGPS cells is controlled at the transcriptional 
level through induction of CRM1 promoter activity, at least for 
HGPS-2 cells. Furthermore, a causal link between progerin and 
CRM1 overexpression was demonstrated because ectopic ex-
pression of progerin in HeLa cells elicited elevated CRM1 levels, 
at least in part through enhancing the binding activity of NF-YA 
(a positive transcription factor) to the CRM1 promoter region, 
and because treatment of HGPS cells with FTI that decreased 
progerin	 旭eve旭s	 resu旭ted	 in	 turn	 in	 downregu旭ation	of	CRMゲs	We	
speculated that exacerbated nuclear export activity might be part 
of the molecular basis underlying HGPS. As proof of concept, we 
evaluated whether inhibition of CRM1 activity by pharmacological 
treatment with LMB has a therapeutic effect on the HGPS phe-
notype. Remarkably, we found alleviation of virtually all HGPS 
hallmarks upon treatment with LMB, including reduced number 
of SA-β-gal positive cells, recovery of peripheral heterochromatin, 
and rescue of lamin B1 downregulation, nucleolar expansion, aug-
mented protein synthesis, and the senescent cellular morphology. 
Furthermore, ectopic overexpression of CRM1 enabled normal 
fibroblasts to acquire all the aging marks aforementioned. Thus, 
CRM1 overexpression is sufficient to recapitulate an aging phe-
notype in the absence of progerin, which indicates that a dysregu-
lated nuclear protein export is an early key event in the pathway 
leading to HGPS.
Most of the cellular processes rescued by LMB treatment are in-
timately related to lamin B1, including nuclear morphology (Vergnes, 
Peterfyp	 Bergop	 Youngp	 ｹ	 Reuep	 ゴググジｫp	 organization	 of	 periphera旭	
heterochromatin, nucleolar plasticity (Camps et al., 2014), and cellu-
旭ar	senescence	ｪDreesenp	Ongp	Chojnowskip	ｹ	Co旭manp	ゴグゲザq	Freund	
et	a旭sp	ゴグゲゴq	Lukasovap	Kovarikp	ｹ	Kozubekp	ゴグゲ芦q	Shimi	et	a旭sp	ゴグゲゲｫs	
Therefore, it is likely that rescue of the HGPS phenotype by treat-
ment with LMB relies mainly on the improvement of lamin B1 levels. 
Consistent with this, exogenous expression of lamin B1 resulted in 
improved nuclear morphology and the recovery of peripheral het-
erochromatin, but failed to alleviate the senescent morphology of 
HGPS cells. Thus, alleviation of the HGPS aging marks appears to 
occur through more than one mechanism; further experiments are 
required to fully delineate pathways underlying the correction of 
aging marks in response to CRM1 inhibition.
A broad spectrum of treatments against HGPS has been tested 
in HGPS fibroblasts (Harhouri et al., 2018), and most of these are 
designed to target progerin. Blocking of progerin farnesylation 
by administration of farnesyltransferase inhibitors corrected nu-
clear structure but failed to alleviate other aging-associated marks 
ｪG旭ynn	ｹ	G旭overp	ゴググズq	Toth	et	a旭sp	ゴググズｫ, while depletion of proge-
ria via rapamycin-mediated activation of autop hagy improved nu-
clear morphology and delayed the onset of senescence (Cao et al., 
2011). In a similar manner, proteasome inhibitor MG132 enhanced 
proliferation and decreased cellular senescence by promoting 
progerin degradation (Harhouri et al., 2017). Finally, treatment 
with	the	chemica旭	JHジ	ame旭iorated	nuc旭ear	defects	and	prevented	
premature senescence by interfering with the harmful interac-
tion between progerin and lamin A (Lee et al., 2016). Alternative 
strategies aimed to repair downstream effects of progerin have 
been proposed as well; treatment with methylene blue rescued 
not only nuclear morphology and heterochromatin loss but also 
mitochondrial function (Xiong et al., 2016), while administration 
of the ROCK inhibitor Y-27632 ameliorated nuclear morphology 
defects and DNA double-strand breaks along with decreased ROS 
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levels and improvement of mitochondrial function (Kang et al., 
2017). In this scenario, pharmacological modulation of CRM1 using 
selective inhibitors clearly provides a viable and promising ther-
apy against HGPS, because this treatment specifically targets and 
corrects the nuclear export mechanism and, more importantly, 
because it alleviates the largest number of HGPS cellular charac-
teristics (Graphical abstract), compared with the aforementioned 
treatments. Furthermore, synthetic selective inhibitors of CRM1 
with pharmacological properties superior to LMB (selinexor/
KPT-330), which have shown to be well-tolerated in human cancer 
c旭inica旭	 tria旭s	 ｪMahipa旭	ｹ	Ma旭afap	ゴグゲ葦ｫp	wou旭d	 faci旭itate	 future	 in	
vivo evaluation of this therapy in HGPS animal models.
Interestingly, we found increased CRM1 levels in primary fibroblast 
from healthy aged donors; however, no progerin was detected in these 
cell cultures. In analogy to the mechanism underlying CRM1 overex-
pression	 in	cancer	ce旭旭s	 ｪvan	der	Watt	ｹ	Leanerp	ゴグゲゲｫp	we	hypothe-
sized that upregulation of CRM1 in fibroblasts from aged individuals 
could be controlled by modulation of the binding activity of transcrip-
tion factors involved in CRM1 promoter activity. Thus, enhanced 
CRM1-mediated nuclear export activity appears to be a key converg-
ing mechanism in both pathological and physiological aging. Consistent 
with this notion, silencing or pharmacological inhibition of CRM1 re-
sulted in extended lifespan in C. elegans (Silvestrini et al., 2018).
In conclusion, we reveal that enhanced nuclear protein export 
is a new hallmark of both HGPS and normal aging. Furthermore, we 
provide evidence that pharmacological inhibition of CRM1 activity 
alleviates the progeroid cellular phenotype (Graphical abstract), 
which delineates CRM1 as potential therapeutic target for HGPS 
and other aging-related diseases.
ジ科 |科E XPERIMENTAL PROCEDURES
ジsゲ科|科Ce旭旭 cu旭turep treatmentsp and transfection
Primary human dermal fibroblasts from patients with HGPS and 
healthy donors (see Table 1) were cultured in MEM (Invitrogen) sup-
plemented with 15% FBS (Invitrogen), nonessential amino acids, and 
antibiotics. All experiments were carried out with fibroblast cul-
tures	at	passage	numbers	ゲゴ･ゲ葦s	Where	indicatedp	fibrob旭asts	were	
treated with 1 nM leptomycin B (LMB; Sigma-Aldrich) for 1, 3, or 
6 days diluted in ethanol to a final concentration of 0.1% in the cul-
ture medium, or with 25 µM of the farnesyl transferase inhibitor (FTI) 
lonafarnib (Sigma-Aldrich) for three days. Fibroblasts were trans-
fected with Lipofe ctamine 3,000 following manufacturer's protocol 
(Invitrogen). Stably transfected fibroblasts were obtained by cultur-
ing them for 12 days with 200 μg/ml G418 (Invitrogen). HeLa cells 
were double-transfected with pFlag-CRM1 vector and vector ex-
pressing either a short hairpin RNA (shRNA) specific for the human 
nuclear transport factor 2 gene (NUTF2) or a scrambled shRNA 
control (GeneCopoeia, Inc.), using Lipofe ctamine 2000 (Invitrogen). 
Stably transfected HeLa cells were obtained by culturing them for 
6 days in the presence of 1 μg/ml puromycin and 800 μg/ml G418. 
Cloning strategies to obtain vectors pEGFP-C1-LB1, pFLAG-CRM1, 
and pCRM1 promoter are provided under request.
ジsゴ科|科Promoter reporter assays
WTp	 HGPS､ゲp	 and	 HGPS､ゴ	 fibrob旭asts	 were	 transfected	 as	 above	
with both the CRM1 promoter vector, which expresses Firefly lucif-
erase under the control of human CRM1 promoter, and the Renilla 
luciferase vector as a control to normalize for differences in trans-
fection efficiency. After 48 hr, the luciferase activity was measured 
using Dual Luciferase Assay kit (Promega).
ジsザ科|科Quantitative chromatin immunoprecipitation 
ｪQ､ChIPｫ assays
Q-ChIP assays were performed as reported previously (Morales-
Lazaro et al., 2010), using 7.8 µg of mouse anti-NF-YA antibodies or 
7.8 µg of mouse IgG (irrelevant control). 20 ng of DNA was used to per-
form quantitative PCR (qPCR) using SYBR Green and primers specific 
to	amp旭ify	the	CRMゲ	promoter	region	ｪvan	der	Watt	ｹ	Leanerp	ゴグゲゲｫs
ジsジ科|科Indirect immunof旭uorescence and confoca旭 
microscopy analysis
Immunostaining and CLSM analyses were carried out following 
standard techniques, using the appropriate primary antibodies 
(Table 2) and the corresponding secondary fluorochrome-con-
jugated	 antibodies	 ｪJackson	 ImmunoResearch	 Laboratoriesｫs	
Images were acquired with the confocal laser system TCS-SP5, 
Leica. Quantification of nucleus/cytoplasm fluorescence inten-
sity was performed as reported previously (Aguilar et al., 2015). 
Morphometric analysis of nuclei was performed with software 
Culture Origin LMNA mutation Age of donor at biopsy Gender
AGグ芦ジ葦ゾ	ｪWTｫ Coriell None 38 M
AGゲゲズゲザ	ｪHGPS┋ゲｫ Coriell G608G 8 F
AGゲゲジゾ芦	ｪHGPS┋ゴｫ Coriell G608G 14 M
AG08470 Coriell None 10 F
AG06290 Coriell None 74 M
AG10884 Coriell None 87 M
AG07725 Coriell None 91 M
TA B L E  ゲ 科 List of human dermal 
fibroblast cultures used in this study
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ImageJ	 ゲsジ葦js	 Nuc旭eo旭ar	 area	 was	 quantified	 by	 measuring	 the	




Fibroblasts seeded on coverslips were stained with SA-β-Gal fol-
lowing manufacturer's instructions (Senescent Cell Histochemical 
Staining Kit, Sigma-Aldrich). Blue-stained cells expressing β-galactosi-
dase (senescent cells) were observed under bright-field microscopy.
ジs葦科|科Western b旭otting
Immunoblotting analyses were carried out following standard protocol. 
Specific proteins were visualized using the Enhanced Chemiluminescence 
ｪECLｾｫ	Western	b旭otting	detection	system	ｪAmersham	Pharmaciap	GE	
Healthcare), according to the manufacturer's instructions.
TA B L E  ゴ 科 List of antibodies and plasmids used in this study
Antibodies
Antibody target Supplier Host
Di旭ution
WB IF
STAT3 Santa	Cruz	Biotechno旭ogy	ｪCatr	sc┋ジ芦ゴｫ Rabbit polyclonal 1:3,000 1:50
B23 Santa	Cruz	Biotechno旭ogy	ｪCatr	sc┋葦グゲザ､aｫ Rabbit polyclonal 1:3,000 1:50
Cyclin B1 Santa	Cruz	Biotechno旭ogy	ｪCatr	sc┋ゼズゴｫ Rabbit polyclonal N/A 1:100
GFP Santa	Cruz	Biotechno旭ogy	ｪCatr	sc┋芦ザザジｫ Rabbit polyclonal 1:1,500 N/A
CRM1 Novus	Bio旭ogica旭sp	ｪCatr	NBゲググ┋ゼゾ芦グゴｫ Rabbit polyclonal 1:4,000 1:250
Lamin B1 Abcam (Cat: ab16048) Rabbit polyclonal 1:3,000 1:250
Fibrillarin Abcam (Cat: ab5821) Rabbit polyclonal N/A 1:50
H3K9me3 Abcam (Cat: ab8898) Rabbit polyclonal 1:3,000 1:1,500
ZO┋ゴ Zymed Laboratories (Cat: 711400) Rabbit polyclonal 1:1,000 1:200
FLAG Cell Signaling Technology (Cat: 2368) Rabbit polyclonal 1:1,000 N/A
Dp71 Genemed Synthesis (Cat: +78Dp71) Rabbit polyclonal N/A 1:100
Lamin A/C Santa	Cruz	Biotechno旭ogy	ｪCatr	sc┋ゴグ葦芦ゲｫ Rabbit polyclonal 1:4,000 N/A
Lamin A/C Hybridoma Bank (Cat: MANLAC3(4C10)) Mouse monoclonal N/A 1:10
HDAC Santa	Cruz	Biotechno旭ogy	ｪCatr	sc┋ゼ芦ゼゴｫ Rabbit polyclonal N/A 1:60
NTF2 Santa	Cruz	Biotechno旭ogy	ｪCatr	sc┋芦グググ芦ｫ Mouse monoclonal 1:150 1:50
Phospho-p70 S6K Santa Cruz Biotechnology (Cat: Sc230) Rabbit polyclonal 1:300 N/A
Phospho-rpS6 Cell Signaling Technology (Cat: 4857) Rabbit monoclonal 1:1,000 N/A
Phospho-eIF2α Cell Signaling Technology (Cat: 9721) Rabbit polyclonal 1:1,000 N/A
Actin Dr. Manuel Hernández, CINVESTAV, Mexico Mouse monoclonal 1:3,000 N/A
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ジsゼ科|科F旭ow cytometry and ce旭旭 pro旭iferation assays
The analysis of cell cycle was carried out on a BD LSRFortessa flow 
cytometer (BD Biosciences), using the ModFit LT software (Verity 
Software House). Cell proliferation was assessed by the 3-(4,5-di-
methylthiazole-25-diphenyl tetrazolium bromide (MTT) assay, as 
reported previously (Velez-Aguilera et al., 2018).
ジs芦科|科Quantitative reverse transcription PCR ｪRT､
qPCRｫ
Total RNA was isolated from fibroblasts using the Direct-zolTM RNA 
MiniPrep Kit (Zymo Research), according to the manufacturer's in-
structions. RT-qPCR was carried on the StepOnePlus Real-Time PCR 
System (Applied Biosystems), using the KAPA SYBR Fast One-Step 
qRT-PCR system (Kapa Biosystems) and following a standard protocol. 
The expression levels for CRM1 mRNA were measured by the 2ΔΔct 
method and normalized to GAPDH mRNA values. Primer sequences 
for CRM1 and GAPDH amplification will be provided under request.
ジsゾ科|科Statistica旭 ana旭ysis
Statistical analyses were performed by the two-tailed unpaired 
Student's t test. Data represent the mean ± SEM from a series of 
three separate experiments, and p values < 0.05 are indicative of sta-
tistica旭	significances	Where	indicatedp	statistica旭	ana旭ysis	was	carried	
out	using	exact	nonparametric	Mann･Whitney	U	test	or	unpaired	t 
test and data were summarized by the mean ± SEM or the mean ± SD 
from a series of three separate experiments. p values < 0.05 were 
considered as significant. All statistical analyses were performed 
using GraphPad Prism 5 software (San Diego).
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